Skip to main content
OpenTrials

Clinical trial condition

Metastatic Triple-Negative Breast Carcinoma

Explore clinical trials studying Metastatic Triple-Negative Breast Carcinoma. Study availability and eligibility vary by location and protocol.

31 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Triple-Negative Breast Carcinoma trial results

Recruiting

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

NCT04348747

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Brain Diseases, Brain Neoplasms, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • University of Virginia Comprehensive Cancer Center Charlottesville, Virginia, United States
View Trial Details
Recruiting

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

NCT03606967

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Smilow Cancer Hospital Care Center at Saint Francis Hartford, Connecticut, United States
View all 30 locations
View Trial Details
Recruiting

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

NCT07137416

Conditions
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, +24 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Recruiting

A Study of Pembrolizumab and Cryoablation in People With Breast Cancer

NCT06246968

Conditions
Breast Cancer, Breast Cancer Stage IV, Breast Diseases, +11 more
Locations
  • Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) Commack, New York, United States
View Trial Details
Recruiting

Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

NCT05422794

Conditions
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, +9 more
Locations
  • Boston Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • NYU Langone Hospital - Long Island Mineola, New York, United States
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
View Trial Details

Related conditions